+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

High Throughput Screening (HTS): Global Strategic Business Report

  • PDF Icon

    Report

  • 273 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1882081

Global High Throughput Screening (HTS) Market to Reach $45.3 Billion by 2030

The global market for High Throughput Screening (HTS) estimated at US$40 Billion in the year 2022, is projected to reach a revised size of US$45.3 Billion by 2030, growing at a CAGR of 1.6% over the analysis period 2022-2030. Consumables / Reagents, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$16.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised -4.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $11.2 Billion, While China is Forecast to Grow at 6.9% CAGR

The High Throughput Screening (HTS) market in the U.S. is estimated at US$11.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 6.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -6.9% and -4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -5.7% CAGR.

Select Competitors (Total 41 Featured) -

  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • Axxam SpA
  • BD Biosciences
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • BioTek Instruments Inc.
  • BMG LABTECH GmbH
  • Charles River Laboratories International Inc.
  • Corning Inc.
  • Danaher Corporation
  • Evotec AG
  • F. Hoffmann-La Roche Ltd.
  • Genedata AG
  • IntelliCyt® Corporation
  • Luminex Corporation
  • Molecular Devices Inc.
  • Pall ForteBio LLC
  • PerkinElmer Inc.
  • Sigma-Aldrich Corp.
  • Tecan Group Ltd.
  • Thermo Fischer Scientific Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for High Throughput Screening (HTS)

What is the estimated value of the Global Market for High Throughput Screening (HTS)?

The Global Market for High Throughput Screening (HTS) was estimated to be valued at $31 Billion in 2020.

What is the growth rate of the Global Market for High Throughput Screening (HTS)?

The growth rate of the Global Market for High Throughput Screening (HTS) is 7.1%, with an estimated value of $50.1 Billion by 2027.

What is the forecasted size of the Global Market for High Throughput Screening (HTS)?

The Global Market for High Throughput Screening (HTS) is estimated to be worth $50.1 Billion by 2027.

Who are the key companies in the Global Market for High Throughput Screening (HTS)?

Key companies in the Global Market for High Throughput Screening (HTS) include Agilent Technologies, Inc., Aurora Biomed Inc., Axxam SpA, BD Biosciences, Beckman Coulter Inc., Bio, Rad Laboratories Inc., BioTek Instruments Inc., BMG LABTECH GmbH and Charles River Laboratories International Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • High Throughput Screening (HTS): A Prelude
  • Recent Market Activity
  • HTS: The Mainstream Technology for Drug Discovery Programs
  • Unparalleled Advantages in Compound Screening Drives Wider Adoption
  • Key Benefits of HTS - An Overview
  • Soaring R&D Spending Creates Conducive Environment for HTS
  • Shift towards High Throughput Research Builds Momentum for HTS
  • Upward Trajectory in Med Tech Sector Generates Parallel Opportunities
  • Stable Economic Outlook to Keep Market Sentiment Intact in the Near Term
  • Developed Regions: Key Revenue Contributors
  • HTS Adoption Continues to Expand in Developing Regions
  • Key Factors Driving Demand for HTS in the Developing Regions
  • Competitive Scenario
  • Leading Players in the World HTS Market
  • M&A Activity
  • High Throughput Screening (HTS) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • Agilent Technologies, Inc. (USA)
  • Aurora Biomed, Inc. (Canada)
  • Axxam SpA (Italy)
  • BD Biosciences (USA)
  • Danaher Corporation (USA)
  • Beckman Coulter, Inc. (USA)
  • Molecular Devices Inc. (USA)
  • Pall ForteBio LLC (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • BioTek Instruments Inc. (USA)
  • BMG LABTECH GmbH (Germany)
  • Charles River Laboratories International, Inc. (USA)
  • Corning Inc. (USA)
  • DiscoveRx Corporation (USA)
  • Evotec AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Genedata AG (Switzerland)
  • IntelliCyt® Corporation (USA)
  • Luminex Corporation (USA)
  • PerkinElmer, Inc. (USA)
  • Sigma-Aldrich Corp. (USA)
  • Tecan Group Ltd. (Switzerland)
  • Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Cell-based Assay: The Widely Used HTS Technology
  • Resolving Technical Limitations: Cornerstone for Future Success of Cell-based HTS
  • HTS Aims to Expand Use Case in Biochemical Applications
  • Label-Free HTS Demonstrates Fastest Growth
  • Lab-on-a-Chip HTS Seeks to Proliferate the Market
  • Bioinformatics HTS Enhanced with Computational Algorithms
  • Positive Prognosis across End-Use Markets to Underpin Revenue Growth
  • Pharmaceutical Industry Leads the Way
  • HTS Deployments Soar in Academia
  • Progressive Advancements in HTS Instruments Accelerate Market Growth
  • Microplate Handling Systems: An Important HTS Instrument Type
  • Liquid Handling Devices: A Necessity in HTS Processes
  • Microscopic Systems Facilitate Seamless Quantitative Analysis
  • Advanced Software Platforms Augment HTS Proficiency
  • Services: An Important Revenue Generating Segment
  • Expansion in Compound Libraries Widens Functional Scope of HTS
  • Compound Libraries Facilitate Simultaneous Functional Genomics & Small Molecule Analysis
  • Laboratory Automation & Miniaturization Spell Opportunities for HTS
  • Miniaturization of Compound Screening Processes Drives Demand for HTS
  • HTS Miniaturization - Technology Developments
  • HTS Robotics Support Miniaturization
  • IVC - A Miniaturized, Powerful HTS Technology
  • HTS Assumes Critical Importance in Target Identification & Validation
  • HTS Gathers Steam in Primary Screening Applications
  • HTS Perceives Bright Future in Stem Cell Research
  • HTS in Kinase Inhibitors Identification
  • HTS in Alzheimer's Disease Drug Discovery
  • HTS for Less Simplified PCR Systems
  • HTFC Eases Metabolic Activity Analysis for Pharmaceutical Drugs
  • Open Access Platforms Widen HTS Audience Base
  • Need for Stringent QA System to Keep Failures at Bay
  • High Throughput Screening (HTS) Vs. High Content Screening (HCS)
  • Rise in Adoption of HCS Technology in HTS Laboratories
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for High Throughput Screening (HTS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for High Throughput Screening (HTS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for High Throughput Screening (HTS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Consumables/Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Consumables/Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Consumables/Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Cell-based Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Cell-based Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Cell-based Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Label-Free Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Label-Free Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Label-Free Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Target Identification & Validation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Target Identification & Validation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for Primary & Secondary Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 26: World Historic Review for Primary & Secondary Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 27: World 16-Year Perspective for Primary & Secondary Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Toxicology Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 29: World Historic Review for Toxicology Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 30: World 16-Year Perspective for Toxicology Assessment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 33: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 34: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 35: World Historic Review for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 36: World 16-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 37: World Recent Past, Current & Future Analysis for Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 38: World Historic Review for Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 39: World 16-Year Perspective for Academic & Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 40: World Recent Past, Current & Future Analysis for Contract Research Organizations (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 41: World Historic Review for Contract Research Organizations (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 42: World 16-Year Perspective for Contract Research Organizations (CRO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 43: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 44: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 45: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 46: World Recent Past, Current & Future Analysis for Consumables / Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 47: World Historic Review for Consumables / Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 48: World 16-Year Perspective for Consumables / Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 49: World High Throughput Screening (HTS) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
AUSTRALIA
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • High Throughput Screening (HTS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • Axxam SpA
  • BD Biosciences
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • BioTek Instruments Inc.
  • BMG LABTECH GmbH
  • Charles River Laboratories International Inc.
  • Corning Inc.
  • Danaher Corporation
  • Evotec AG
  • F. Hoffmann-La Roche Ltd.
  • Genedata AG
  • IntelliCyt® Corporation
  • Luminex Corporation
  • Molecular Devices Inc.
  • Pall ForteBio LLC
  • PerkinElmer Inc.
  • Sigma-Aldrich Corp.
  • Tecan Group Ltd.
  • Thermo Fischer Scientific Inc.